BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30723775)

  • 1. Heritability in frontotemporal tauopathies.
    Forrest SL; Halliday GM; McCann H; McGeachie AB; McGinley CV; Hodges JR; Piguet O; Kwok JB; Spillantini MG; Kril JJ
    Alzheimers Dement (Amst); 2019 Dec; 11():115-124. PubMed ID: 30723775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
    Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
    Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Protein and Frontotemporal Dementias.
    Goedert M; Spillantini MG; Falcon B; Zhang W; Newell KL; Hasegawa M; Scheres SHW; Ghetti B
    Adv Exp Med Biol; 2021; 1281():177-199. PubMed ID: 33433876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Practical Approach to Differentiate the Frontotemporal Tauopathy Subtypes.
    Forrest SL; Halliday GM; Sizemova A; van Roijen M; McGinley CV; Bright F; Kapur M; McGeachie AB; McCann H; Shepherd CE; Tan RH; Affleck AJ; Huang Y; Kril JJ
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1122-1126. PubMed ID: 32954432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heritability and genetics of frontotemporal lobar degeneration.
    Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
    Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
    Dickson DW; Kouri N; Murray ME; Josephs KA
    J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
    Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
    J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progressive nonfluent aphasia].
    Murayama S; Saito Y
    Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of family histories in FTLD subtypes and related tauopathies.
    Goldman JS; Farmer JM; Wood EM; Johnson JK; Boxer A; Neuhaus J; Lomen-Hoerth C; Wilhelmsen KC; Lee VM; Grossman M; Miller BL
    Neurology; 2005 Dec; 65(11):1817-9. PubMed ID: 16344531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropathologic Subtypes of Frontotemporal Lobar Degeneration].
    Tada M; Kakita A
    Brain Nerve; 2018 May; 70(5):501-516. PubMed ID: 29760288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and regional vulnerability in frontotemporal tauopathies.
    Forrest SL; Kril JJ; Halliday GM
    Acta Neuropathol; 2019 Nov; 138(5):705-727. PubMed ID: 31203391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal lobar degeneration--tau as a pied piper?
    Tolnay M; Probst A
    Neurogenetics; 2002 Oct; 4(2):63-75. PubMed ID: 12481984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal lobar degeneration: current concepts in the light of recent advances.
    Kumar-Singh S; Van Broeckhoven C
    Brain Pathol; 2007 Jan; 17(1):104-14. PubMed ID: 17493044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited review: Neuropathology of tauopathies: principles and practice.
    Kovacs GG
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies.
    Nijholt DA; van Haastert ES; Rozemuller AJ; Scheper W; Hoozemans JJ
    J Pathol; 2012 Apr; 226(5):693-702. PubMed ID: 22102449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.